Business
European international award win
European international award win.
About this update from Diaceutics Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 4996F\n Diaceutics PLC\n 17 November 2020\n \n \n \n \n Diaceutics PLC\n \n \n (\"Diaceutics\" or the \"Company\")\n \n \n \n \n \n European international award win \n \n \n \n \n \n Diaceutics PLC, (AIM: DXRX), \n the world's first diagnostic network provider for Precision Medicine, \n DXRX - The Diagnostic Network®, \n has won the International Star Award as part of the \n European Small and Mid Cap Awards 2020. The awards are a joint initiative of the European Commission, the Federation of European Securities Exchanges and European Issuers.\n \n \n \n In June 2020, Diaceutics was recognised as 'IPO of the Year' at the 8th Annual Small Cap Awards, and was subsequently shortlisted for this International Star Award, alongside \n Proeduca Altus and Sanlorenzo, by an \n independent jury established by the European Commission.\n \n \n \n \n \n Since \n \n admission to AIM in\n \n March 2019, Diaceutics has maintained its commitment to addressing key issues hindering cancer testing.\n \n \n The International Star Award is presented to a newly listed mid-cap company that has demonstrated strategic growth internationally, defined by critical success factors such as international sales expansion, increased profitability and market share growth.\n \n Small and mid-cap companies are nominated for four separate categories which include International Star, Rising Star, Star of Innovation and Star of 2020.\n \n \n \n \n \n The International Star Award win marks a significant period for Diaceutics, following the successful launch of DXRX - The Diagnostic Network® in October 2020. This platform is designed to improve the efficiency of cancer patient testing globally, reducing the current protracted timeline for a patient to secure optimal treatment from years to months.\n \n \n \n \n \n \n Philip White, Diaceutics CFO said: \n \n \n \"I'd like to offer a\n \n \n sincere thanks to everyone involved in the European Small and Mid Cap Awards. It's\n a great honour for Diaceutics to be recognised with this International Star Award. This represents a seal of approval for the inroads we have made in recent years, particularly since our IPO. This award is really for our talented workforce, whose dedication and skill have driven this period of success for Dia...